Skip to main content
Precigen, Inc. (PGEN)
NASDAQ: PGEN · Real-Time Price · USD
3.510
+0.190 (5.72%)
At close: Mar 9, 2026, 4:00 PM EDT
3.470
-0.040 (-1.14%)
After-hours: Mar 9, 2026, 7:59 PM EDT

Precigen Revenue

Precigen had revenue of $2.92M in the quarter ending September 30, 2025, with 206.61% growth. This brings the company's revenue in the last twelve months to $6.31M, up 59.20% year-over-year. In the year 2024, Precigen had annual revenue of $3.93M, down -36.95%.

Revenue (ttm)
$6.31M
Revenue Growth
+59.20%
P/S Ratio
196.85
Revenue / Employee
$44,119
Employees
143
Market Cap
1.24B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20243.93M-2.30M-36.95%
Dec 31, 20236.23M-20.68M-76.87%
Dec 31, 202226.91M12.64M88.61%
Dec 31, 202114.27M-17.73M-55.40%
Dec 31, 202031.99M-58.73M-64.74%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Pharming Group 362.27M
AbCellera Biologics 75.13M
EyePoint 31.37M
Septerna 22.05M
Inventiva 19.93M
Taysha Gene Therapies 6.31M
DBV Technologies 5.50M
AtaiBeckley 4.09M
Revenue Rankings

PGEN News

More News